Skip to content
value.today

OrthoPediatrics Corp.

🇺🇸 Warsaw, Indiana, USAHealth CareFounded 2007

Formerly OrthoPediatrics LLC

Total raised
$52 M
2 rounds on record
Latest round
$39 M
May 2014
First round on record
Jan 2008
Today
Went public
See the company page

OrthoPediatrics Corp. is listed today as OrthoPediatrics Corp.: market value, financials and filings are on its company page.

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of OrthoPediatrics Corp.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2014$39 MNo. 2$10 to $50 million

OrthoPediatrics Corp.: Raise no. 2, May 2014

Investors in this round

0 investors had bought by the notice of Jun 3, 2014: 0 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for OrthoPediatrics Corp. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$39 M of $39 M offered
Smallest investment taken
$5,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel J Gerritzen · Executive Officer
  • David Bailey · Executive Officer, Director
  • Greg Odle · Executive Officer, Director
  • Mark C Throdahl · Executive Officer, Director
  • Steve C Miller · Executive Officer
  • Bernie B Berry III · Director
  • Bryan C Hughes · Director
  • David C Pelizzon · Director
  • Kevin C Unger · Director
  • Oscar Moralez · Director
  • Peter C Munson · Director
  • Terry Schlotterback · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Daniel J. Gerritzen, Vice President and General Counsel. Source: SEC Form D, newest notice filed Jun 3, 2014. Read the notice at the SEC.

equitySEC
Jan 2008$13 MNo. 1$10 to $50 million

OrthoPediatrics Corp.: Raise no. 1, Jan 2008

Investors in this round

202 investors had bought by the notice of Jul 23, 2009: 202 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for OrthoPediatrics Corp. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$13 M of $17 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$1,090,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bob von Seggern · Executive Officer
  • Daniel J Gerritzen · Executive Officer
  • David Bailey · Executive Officer, Director
  • Gary Barnett · Executive Officer, Director
  • Greg Downey · Executive Officer, Director
  • Greg Odle · Executive Officer, Director
  • Isaac Mensah · Executive Officer, Director
  • Jeff Minaudo · Executive Officer
  • Mark Scrafton · Executive Officer
  • Nick A Deeter · Executive Officer, Director
  • Terry Schlotterback · Executive Officer, Director
  • Thomas Slagle · Executive Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Daniel J. Gerritzen, Vice President of Legal and General Counsel. Source: SEC Form D, newest notice filed Jul 23, 2009. Read the notice at the SEC.

equity, debtSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company OrthoPediatrics Corp., its revenue in fiscal 2025 came from these product and service lines: Trauma and deformity $166.30 million (70%), Scoliosis $66.05 million (28%), Sports medicine/other $4 million (2%).

    Annual report (SEC XBRL) · Dec 2025

  • OrthoPediatrics Corp. chose not to state its revenue in its newest notice of a funding round (Jun 2014).

    SEC Form D · Jun 2014

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jun 2014

Products and services#

No products or services of OrthoPediatrics Corp. are on record.

Investors#

3 named in official filings. Open an investor to see everything it has backed.

Investors in OrthoPediatrics Corp.
InvestorKindAmountRoundRoleSource
Bernie B. Berry IIIPersonnot statednot statedHeld Series B preferred stock, director (Form 3, 2017)SEC Form 3
Mark C. ThrodahlPersonnot statednot statedHeld Series B preferred stock, director (Form 3, 2017)SEC Form 3
Squadron Capital LLCFund or asset managernot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2017)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 202 investors.

Largest shareholders today

Institutions holding OrthoPediatrics Corp. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by OrthoPediatrics Corp.
NameRoleNamed in
Daniel J GerritzenExecutive officerJun 2014
David BaileyExecutive officerJun 2014
Greg OdleExecutive officerJun 2014
Mark C ThrodahlExecutive officerJun 2014
Steve C MillerExecutive officerJun 2014
Bob von SeggernExecutive officerJul 2009
Gary BarnettExecutive officerJul 2009
Greg DowneyExecutive officerJul 2009
Isaac MensahExecutive officerJul 2009
Jeff MinaudoExecutive officerJul 2009
Mark ScraftonExecutive officerJul 2009
Nick A DeeterExecutive officerJul 2009
Terry SchlotterbackExecutive officerJul 2009
Thomas SlagleExecutive officerJul 2009
Bernie B Berry IIIDirectorJun 2014
Bryan C HughesDirectorJun 2014
David BaileyDirectorJun 2014
David C PelizzonDirectorJun 2014
Greg OdleDirectorJun 2014
Kevin C UngerDirectorJun 2014
Mark C ThrodahlDirectorJun 2014
Oscar MoralezDirectorJun 2014
Peter C MunsonDirectorJun 2014
Terry SchlotterbackDirectorJun 2014
Gary BarnettDirectorJul 2009
Greg DowneyDirectorJul 2009
Isaac MensahDirectorJul 2009
Nick A DeeterDirectorJul 2009

Went public since 2017. Its SEC number is that of a company listed on a stock exchange.